POWERUP ACQUISITION COR-CL A (PWUP) Stock News

NASDAQ:PWUP - KYG7207P1037 - Common Stock

9.24 USD

-1.61 (-14.84%)

Last: 2/14/2025, 8:01:28 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

PWUP Latest News, Press Relases and Analysis

All

Press Releases

6 months ago - By: ACCESS Newswire - Mentions: ASBP

Aspire Biopharma Holdings, Inc., Announces Public Listing on Nasdaq

6 months ago - By: ACCESS Newswire

Aspire Biopharma Holdings, Inc., Announces Public Listing on Nasdaq

9 months ago - By: Halper Sadeh LLC - Mentions: ARCH AG USAP

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates USAP, ARCH, PWUP, AG on Behalf of Shareholders

10 months ago - By: Halper Sadeh LLC - Mentions: ROIC RVNC

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ROIC, PWUP, RVNC on Behalf of Shareholders

10 months ago - By: Halper Sadeh LLC - Mentions: INSI YOTA CPTN

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates YOTA, PWUP, CPTN, INSI on Behalf of Shareholders

a year ago - By: Halper Sadeh LLC - Mentions: CBZ ESGR

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CBZ, PWUP, ESGR on Behalf of Shareholders

a year ago - By: PowerUp Acquisition Corp.

Aspire Biopharma, Inc., and PowerUp Acquisition Corp. Announce Business Combination Agreement to Create Nasdaq-listed Biopharmaceutical Company Driving Breakthrough Innovations in FDA Approved Drugs, Nutraceuticals and Supplements

a year ago - By: PowerUp Acquisition Corp.

Aspire Biopharma, Inc. Signs Letter of Intent to Create a Publicly Listed, Drug Delivery Company Through a Business Combination with PowerUp Acquisition Corp.

a year ago - By: PowerUp Acquisition Corp.

PowerUp Acquisition Corp. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q

a year ago - By: PowerUp Acquisition Corp.

PowerUp Acquisition Corp. Announces Postponement of Extraordinary General Meeting of Shareholders

a year ago - By: PowerUp Acquisition Corp.

PowerUp Acquisition Corp. Announces Postponement of Extraordinary General Meeting of Shareholders

2 years ago - By: PowerUp Acquisition Corp.

PowerUp Acquisition Corp. and Visiox Pharmaceuticals, Inc. Announce Filing of Registration Statement on Form S-4 to the SEC in Connection with the Previously Announced Proposed Business Combination

2 years ago - By: PowerUp Acquisition Corp.

Visiox Pharmaceuticals, Inc., a Commercial-Stage Biopharmaceutical Company to be Listed on Nasdaq Through a Business Combination with PowerUp Acquisition Corp.

3 years ago - By: PowerUp Acquisition Corp.

PowerUp Acquisition Corp. Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing April 11, 2022